Originally called on by Fidelity to provide expert analysis of drugs, Dr. Henderson has collaborated with Dr. Weintraub to developed models for over 300 drugs that are either on the market or in clinical development. Prior to joining inThought in January 2009, Dr. Henderson and Dr. Weintraub performed investment research at BiotechTracker, Hibernia Southcoast Capital, Variant Research, and Reuters Insight. Dr. Henderson earned a medical degree from Cornell University and a Bachelor of Arts in Linguistics from Northwestern University.
Dr. Henderson is an internal medicine specialist and clinical geneticist practicing in Southern California and serving domestic and international clientele. Dr. Henderson, an applied health services research expert, has consulted for academia and industry on the biotechnology industry and has authored medical literature and healthcare economics literature.